Parp Inhibitor Biomarkers Market
PARP INHIBITOR BIOMARKERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)
PARP Inhibitor Biomarkers Market, by Product & Services (Product Type (Kits and Assays) and Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing and Others)), by Application (Breast Cancer, Ovarian Cancer, and Others (Prostate, Pancreatic, etc.) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -
- Published In: 27 Apr, 2026
- Code: CMI3762
- Page number: 176
- Formats: Excel and PDF
- Industry: Clinical Diagnostic
-
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033
Table of Contents (Version-2026)
Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type and Services
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Market Dynamics
Global PARP inhibitor biomarkers
Market
- Economic Impact
- Impact on Supply and Demand
Global PARP inhibitor biomarkers Market, By Product Type and Services, 2021 – 2033 (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022–2033
- Segment Trends
- Product Type
- Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Segment Trends
- Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Segment Trends
- Tests
- Services
- BRCA 1 & 2 Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- HRD Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- HRR Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- BRCA 1 & 2 Testing
- Introduction
Global PARP inhibitor biomarkers Market, By Application, 2021 – 2033 (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022–2033
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Ovarian Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Introduction
Global PARP inhibitor biomarkers Market, By Regions, 2021 – 2033 (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022–2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type and Services, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Application , and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, By Product Type and Services, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Application , and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type and Services, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Application , and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, By Product Type and Services, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Application , and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, By Product Type and Services, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Application , and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type and Services, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Application , and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
Competitive Landscape
- Company Profiles
- Abbott Diagnostics (Abbott Laboratories) *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Myriad Genetics, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Invitae Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- NeoGenomics Laboratories, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- BPS Bioscience
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Antibodies Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Networks LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Beckman Coulter, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Euro Diagnostica AB, F.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Qiagen NV
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Siemens Healthcare GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Augurex Life Sciences Corp.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bio Rad Laboratories Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Exagen Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Genway Biotech, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Microdrop LLC (imaware)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Svar Life Science AB
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Abbott Diagnostics (Abbott Laboratories) *
- Company Profiles
Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 34 market data tables and 26 figures on “Global PARP inhibitor biomarkers Market – Global forecast to 2033
-
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
EXISTING CLIENTELE
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
